Submitted by jrborbolla on Wed, 03/18/2009 - 12:31.
Hello, I am Jose Borbolla, I´m a hematologist and a bone marrow transplanter in Mexico (www.imeht.org).
Prednisone, like most corticosteroids is used in lymphomas (Hodgkins and non-Hodgkins) and other lymphoid neoplasias (such as multiple myeloma) because it has anti-tumoral effect. In some cases very high doses are used. Event though there are a number of corcitosteroids, proven chemotherapy regimens usually use a particular one, and doctors are sometimes careful not to change it as not to decrease the effectiveness of the therapy. The good news is that the use of Prednisone is usually not prolonged and the side-effects usually go away once the treatment stops. I am sure your doctor has warned you regarding the increase in blood glucose that sometimes appears, as well as possible fatigue or weakness. Hope this has been helpful.
JRBE
The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.
SupportGroups.com aims to build awareness and provide support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.
Since the early 1970s, incidence rates for non-Hodgkin’s lymphoma have nearly doubled. Improved diagnosis has contributed greatly to the increase as doctors better understand cancer of lymphocytes and can distinguish it from other diseases.